振華股份(603067.SH):全資子公司民豐化工擬吸收合併新華化工
格隆匯9月22日丨振華股份(603067.SH)公佈,為進一步整合及優化現有資源配置,提高資產的管理效率和運營效率,優化公司股權結構,降低管理成本,公司全資子公司重慶民豐化工有限責任公司(“民豐化工”)吸收合併其全資子公司重慶新華化工有限公司(“新華化工”)。吸收合併後,民豐化工存續,新華化工予以註銷。
民豐化工通過吸收合併的方式合併新華化工的全部資產、債權債務、業務及人員,吸收合併完成後,民豐化工存續,新華化工註銷。合併雙方將依法定程序辦理相關資產移交、資產權屬變更登記、變更註銷等相關手續,涉及工商、税務、無形資產等事項的,按照相關法律法規及行政管理規定執行。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.